Extrib 30/60/90/120 mg FC tablet.
Clinical Summary
Quick overview from the medicine insert
Indication
Symptomatic relief of osteoarthritis, rheumatoid arthritis, ankylosing spondylitis, acute gouty arthritis, acute pain, primary dysmenorrhoea, and post-operative dental pain.
Dosage (summary)
OA: 30 mg daily; RA/ankylosing spondylitis: 90 mg daily; acute pain: 90-120 mg daily for max 8 days; gout: 120 mg daily; dysmenorrhoea: 120 mg daily.
Special Populations
- Elderly
- Hepatic insufficiency
- Renal insufficiency
Pregnancy & Breastfeeding
Contraindicated in pregnancy and lactation; may affect fetal ductus arteriosus.
Key Drug Interactions
- Lithium
- Warfarin
- Methotrexate
- Diuretics
- ACE inhibitors
Contraindications
- Hypersensitivity to etoricoxib
- Active peptic ulceration
- Severe hepatic dysfunction
- Renal clearance < 30 mL/min
- Uncontrolled hypertension
- Pregnancy and lactation
Common side effects
- Hypertension
- Dizziness
- Gastrointestinal disorders
- Oedema
- Hypersensitivity reactions
Counselling Points
- Take with or without food.
- Monitor blood pressure regularly.
- Report any signs of skin rash or hypersensitivity.
- Avoid use in pregnancy and breastfeeding.
Serious warnings
- Cardiovascular events risk
- Gastrointestinal complications
- Serious skin reactions
- Renal injury
The Extrib 30/60/90/120 mg FC tablet. professional information leaflet below is the property of Pharma Dynamics and is provided on Medinsert exactly as issued, with no.. alterations or editorial changes. We make every effort to keep content current by updating documents as soon as new versions become available. Medinsert serves as a trusted access point for healthcare professionals, but does not replace official sources or clinical judgement. For more details, please read our full disclaimer. read more>>
This content is for registered healthcare professionals
Sign in or create a free account to read the full package insert.
Free for HPCSA-registered professionals. Powered by Medinsert.